Harvard Pulmonary And Critical Care Medicine 2026

Description Description Videos PDFs Include: 63 ( 5) Videos (.mp4) 54 PDFs, size Target Audience: pulmonologists, intensivists, and critical care physicians, internists, hospital medicine physicians Information: 1. Overview The Harvard Pulmonary And Critical Care Medicine 2026 course provides a comprehensive, evidence-based review of the latest advancements in pulmonary, critical care, and sleep medicine. The program equips clinicians with cutting-edge strategies for diagnosing and managing complex respiratory conditions, intensive care emergencies, and emerging therapeutics to improve patient outcomes in both outpatient and ICU settings. Course Date: April 27, 2026 – May 1, 2026 Pulmonary and Critical Care Medicine 2026 offers a comprehensive update on state-of-the-art evaluation, diagnosis, treatment, and procedures for patients with common, rare, and challenging pulmonary conditions and for patients requiring critical care. Pulmonary and Critical Care Medicine is a live online course, using live streaming, electronic Q&A, and other remote learning technologies. This comprehensive course provides education and updates to optimize your care of patients with pulmonary conditions and patients requiring critical care. Physicians, NPs, and PAs can rely on this program to enhance their practice and advance their knowledge with evidence-based strategies for evaluation, diagnosis, treatment, and procedures. All sessions are led by master clinicians who deliver information in inspiring and entertaining ways and provide specific recommendations to incorporate the latest updates into your practice. This year’s program covers: New in 2026: breaking news updates in pulmonary and critical care medicine The most current guidelines for treating sepsis Evidence-based treatment of ARDS Interventional pulmonology: diagnostic procedures, therapeutic interventions, and as an alternative to surgery High-flow oxygen therapy for respiratory failure Updates on biologics in asthma and other lung disease Diagnosis and management of bleeding diatheses in the ICU New concepts in the use of vasopressors in septic shock New drugs and combinations in pulmonary hypertension New evidence on sedation, analgesia, and early mobility in the ICU Point-of-care pulmonary ultrasound in the intensive care unit Lung microbiome: emerging implications for lung health Emerging evidence for targeted temperature management Steroid-sparing agents for interstitial lung disease Pulmonary embolus: the latest treatment strategies Guidance to conduct end-of-life discussions Updates in pulmonary pathology New treatment options in cystic fibrosis Handling neurologic and surgical emergencies in the medical ICU A Practical, Comprehensive Update for Busy Clinicians This program delivers comprehensive updates to improve evaluation, diagnosis, and management of the broad array of pulmonary and critical care conditions: IPF Non-IPF ILD ARDS Sarcoidosis Lung transplantation Bronchiectasis Cystic fibrosis Lung nodules Lung cancer Sepsis Pleural disease Pneumonia Tuberculosis Thromboembolism COPD Asthma GERD Neurologic issues in the ICU Sleep-disordered breathing Surgical emergencies Acute pancreatitis Atypical mycobacterial disease Pulmonary hypertension Post-cardiac arrest care Hypersensitivity pneumonitis Ventilator management Participants also have access to expanded question and answer sessions with faculty throughout the program, which promotes discussion of the complexity of real-world care. 2. Learning Objectives Evaluate the pathophysiology of lung disease and critical illness, including key pathologic and radiologic features Apply evidence from recent literature to clinical case management Apply new clinical practice guidelines to improve patient outcomes Utilize diagnostic and therapeutic tools offered by specialists outside of pulmonary and critical care medicine to optimally care for complicated patients Review the latest evidence and best clinical practices for fluid resuscitation and vasopressor use 3. Target Audience Best for pulmonologists, intensivists, and critical care nurses who want updates on respiratory diseases, ICU management, and sleep medicine. Who Should Participate Physicians, Nurse Practitioners, and Physician Assistants in the fields of: Pulmonology Critical Care Internal Medicine Hospital Medicine … and other medical professionals who want to advance their knowledge of pulmonary and critical care medicine 4. Topics 01 Breaking News in Pulmonary Medicine Dr. Benjamin Medof 02 Cystic Fibrosis Understanding CFTR and New Treatment Dr. Isabel Neuringer 03 Beyond Cystic Fibrosis Diagnosis and Management of Non-CF Bronchiectasis Dr. Christopher Richards 04 Lung Transplantation 2026 Referral Patient Selection, Lung Allocation, and COVID Dr. Brian Keller 05 Exercise and Cardiopulmonary Disorders Indications and Interpretation Dr. C. Corey Hardin 06 Q&A with Speakers Drs. Isabel Neuringer, Christopher Richards, Brian Keller, and C. Corey Hardin 07 Pulmonary Pathology Interstitial Lung Disease Dr. Lida Hariri 08 Looking Deeper Patterns and Insights from Chest Radiology Dr. Amita Sharma 09 Evolving Concepts in the Diagnosis and Management of Connective Tissue Disease-Associated ILD Dr. Barry Shea 10 Hypersensitivity Pneumonitis Pigeons, Farmers, and Hot Tubs, Oh My! Dr. Sydney Montesi 11 Treatment Challenges of Pulmonary Sarcoidosis Dr. Robert Hallowell 12 Diagnosis and Management of IPF When, Why, and How to Use the Newest Drugs Dr. Grace Peloquin 13 Q&A with Speakers Drs. Kathryn Hibbert, Angela Frank, Barry Shea, Robert Hallowell, Grace Peloquin, and Sydney Montesi 14 Sedation, Analgesia, and Early Mobility The State ofthe Artin 2026 Dr. Crystal North 15 Noninvasive Respiratory Supportfor Acute Respiratory Failure Less May NOT Be Best Carolyn La Vita, MHA, RRT 16 Novel Ventilator Modes The Hype and Reality Carolyn La Vita, MHA, RRT 17 ARDS State-of-the-Art Strategies to Protectthe Lung Dr. Jehan Alladina 18 After the ICU Post-ICU Care Syndrome and Recovery Dr. George Alba 19 Q&A with Speakers Drs. Kathryn Hibbert, Angela Frank, Crystal North, George Alba, and Jehan Alladina, and Carolyn La Vita, MHA, RRT 20 From Ancient Egyptto Balanced Crystalloids Medicine’s Attempts to Manage Sepsis Dr. Eric Schmidt 21 Fluid Responsiveness Dr. David Ziehr 22 Vasopressors in Septic Shock Old Friends and New Dr. Jason Griffith 23 Approach to Empiric Antibiotics in the ICU Dr. Alyssa Letourneau 24 Approach to the Immunocompromised Critically Ill Patient Dr. Lisa Bebell 25 Renal Replacement Therapy in the ICU What and When to Start(or Not) Dr. Andrew Allegretti 26 Q&A with Speakers Drs. Kathryn Hibbert, Lisa Bebell, Alyssa Letourneau, David Ziehr, Eric Schmidt, Jason Griffith, and Andrew Allegretti 27 Common Neurologic Issues in the ICU Dr. Sahar Zafar 28 TTM and Neuro-prognostication After Cardiac Arrest Dr. David Greer 29 Surgical Emergencies in the Medical ICU Dr. Noelle Saillant 30 Updates in Management of Acute Pancreatitis Dr. Casey Luckhurst 31 Advanced Cardiac Supportin the ICU Dr. David Dudzinski 32 Q&A with Speakers Drs. Sahar Zafar, David Greer, Noelle Saillant, David Dudzinski, and Casey Luckhurst 33 Breaking Updates in Critical Care Dr. Kathryn Hibbert 34 Management ofthe Acutely Hemorrhaging Patient Dr. Raghu Chivkula 35 Point-of-Care Ultrasound in the Intensive Care Unit Dr. Jonah Rubin 36 Pneumonia (Community and Hospital Acquired) Using the Newest Guidelines to Provide Evidence-Based Care Dr. Joshua Metlay 37 Prognosis and Uncertainty in the ICU Dr. Emily Rubin 38 Palliative Care in Advanced Lung Disease Dr. Jaclyn Shameklis 39 Q&A with Speakers Drs. Kathryn Hibbert, Emily Rubin, Joshua Metlay, Jaclyn Shameklis, and Jonah Rubin 40 Pleural Disease 2026 Updates Dr. Fayez Kheir 41 Interventional Pulmonology in 2026 Dr. Colleen Keyes 42 Interventional Bronchoscopy in COPD Valves, Coils, and Beyond Dr. Colleen Keyes 43 Treatment of Non-Small Cell Lung Cancer Traditional Chemotherapy, Targeted Therapy, and Immunotherapies Dr. Allison Chang 44 COPD 2026 Dr. Walter O’Donnell 45 Q&A with Speakers Drs. Angela Frank, Fayez Kheir, Colleen Keyes, and Walter O’Donnell 46 Aspergillus Lung Disease Dr. Rod Rahimi 47 Asthma What’s New in 2026 Dr. Miranda Theodore 48 New Therapeutics in Lung Disease The Age of Immunotherapy Dr. Benjamin Medof 49 A Strategic Approach to the Management of Pulmonary Nodules Dr. Angela Frank 50 Tuberculosis in 2026 Dr. Jodian Pinkney 51 Nontuberculous Mycobacterial Disease Navigating the Labyrinth Dr. Rocio Hurtado 52 Q&A with Speakers Drs. Kathryn Hibbert, Benjamin Medof, Rocio Hurtado, Angela Frank, Rod Rahimi, and Jodian Pinkney 53 Thrombotic Mechanisms and Antithrombotic Agents How Do the New Oral Agents Fitin 2026 Dr. Rachel Rosovsky 54 Pulmonary Embolism An Update Dr. Alison Witkin 55 Pulmonary Hypertension Categorization and Evaluation Dr. Josanna Rodriguez-Lopez 56 Pulmonary Hypertension Management Dr. Alexandra Wong 57 Vasculitis and ANCA Dr. Rachel Knipe 58 Q & A with Speakers Drs. Alison Witkin, Josanna Rodriguez-Lopez, Alexandra Wong, Angela Frank, and Rachel Rosovsky 59 Obstructive Sleep Apnea Dr. James Mojica 60 Central Sleep Apnea 2026 Dr. James Mojica 61 Sleep Diagnostics Dr. Katherine Dudley 62 Noninvasive Ventilation Dr. Katherine Dudley 63 Q & A with Speakers Drs. James Mojica and Katherine Dudley